Orbis Holdings’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$10.9M Hold
107,723
0.09% 62
2015
Q3
$10.6M Sell
107,723
-24,178
-18% -$2.69M 0.09% 64
2015
Q2
$15.4M Sell
131,901
-1,161,985
-90% -$127M 0.12% 62
2015
Q1
$127M Sell
1,293,886
-1,272,634
-50% -$129M 1.01% 31
2014
Q4
$242M Sell
2,566,520
-1,691,781
-40% -$175M 1.84% 19
2014
Q3
$453M Sell
4,258,301
-1,888,276
-31% -$185M 3.6% 6
2014
Q2
$510M Buy
6,146,577
+3,501,459
+132% +$273M 4.19% 6
2014
Q1
$187M Buy
2,645,118
+1,939,660
+275% +$152M 1.49% 25
2013
Q4
$53M Sell
705,458
-37,591
-5% -$2.62M 0.37% 54
2013
Q3
$46.7M Sell
743,049
-154,000
-17% -$9.2M 0.35% 48
2013
Q2
$45.9M Buy
+897,049
New +$46.8M 0.37% 46

Other funds holding GILD

Orbis Holdings's GILD Position: Q4 2015 in Review

Orbis Holdings held its Gilead Sciences (GILD) position steady in Q4 2015 at 107,723 shares worth $10.9M. The position accounts for 0.09% of the portfolio, ranked #62.

Orbis Holdings first reported a position in GILD in Q2 2013 and has held it in 11 quarters since. The position peaked at $510M in Q2 2014. 1,630 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

  • Orbis Holdings held 107,723 shares of Gilead Sciences worth $10.9M as of Q4 2015.
  • Orbis Holdings left its Gilead Sciences share count unchanged in Q4 2015.
  • Gilead Sciences made up 0.09% of Orbis Holdings's portfolio in Q4 2015, its #62 holding.
  • Orbis Holdings first reported a position in Gilead Sciences in Q2 2013 and has held it in 11 quarters since.
  • Orbis Holdings's Gilead Sciences position peaked at $510M in Q2 2014.
  • 1,630 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Orbis Holdings's 13F filing for Q4 2015, filed 16 Feb 2016.